The Synechococcus elongatus COG0325 gene pipY functionally interacts with the nitrogen regulatory gene pipX. As a first step toward a molecular understanding of such interactions, we characterized PipY. This 221-residue protein is monomeric and hosts pyridoxal phosphate (PLP), binding it with limited affinity and losing it upon incubation with D-cycloserine. PipY crystal structures with and without PLP reveal a single-domain monomer folded as the TIM barrel of type-III fold PLP enzymes, with PLP highly exposed, fitting a role for PipY in PLP homeostasis. The mobile PLP phosphate-anchoring C-terminal helix might act as a trigger for PLP exchange. Exploiting the universality of COG0325 functions, we used PipY in site-directed mutagenesis studies to shed light on disease causation by epilepsy-associated mutations in the human COG0325 gene PROSC.
Cyanobacteria, the chloroplasts ancestors [1] , are very ancient, widespread, and abundant [2] photosynthetic bacteria that play key roles in global oxygen, CO 2 , and nitrogen fluxes [3] . Nitrogen incorporation is highly regulated in cyanobacteria [4] . The small protein PipX [5, 6] is a key player, as highlighted by transcriptomic studies in Synechococcus elongatus PCC7942 (from now on S. elongatus) [7] . PipX regulation, mediated by the carbon/energy/nitrogen signaling protein PII and the gene expression regulator NtcA [5, 8, 9] , also involves newly discovered partners as PlmA [10] .
Very recently, the synteny in cyanobacteria of the mutually adjacent pipX and pipY genes led to the identification in S. elongatus of functional interactions between these two genes [11] . pipY is a member of the highly widespread [12] and intriguing COG0325 gene family [11] that includes Escherichia coli yggS, a gene that when inactivated causes a phenotype of pyridoxine toxicity and pleiotropic changes related to amino acid-related metabolism [12] [13] [14] . Inactivation of pipY in S. elongatus [11] also enhanced pyridoxine toxicity and led to increased sensitivity to antibiotics that target pyridoxal phosphate (PLP) such as D-cycloserine (DCS) [15] ; these two traits were influenced by various amino acids [11] . Pleiotropic changes were also observed in null mutants of the COG0325 genes ylmE of Bacillus subtilis [16] and PROSC of humans [17, 18] . The deficiency of the human gene was reported to cause vitamin B 6 -dependent epilepsy [17, 18] . The pleiotropy of the changes associated with COG0325 mutations is best explained if the COG0325 products, which are PLP proteins [19] , rather than being enzymes, play key roles in PLP homeostasis. These roles remain uncharacterized molecularly.
Striving toward delineation of the roles of PipY, we decided to characterize physically and structurally PipY from S. elongatus. Such characterization appeared pertinent, given the extensive in vivo functional data collected for its corresponding gene [11] . Furthermore, there was only one published analysis of the structure of another COG0325 protein, YBL036C from yeast [19] , an organism that is phylogenetically distant from cyanobacteria. The YBL036C structure had been determined as a part of a structural genomics effort, and the biological in vivo role of YBL036C had not been specifically explored. In addition, the structural knowledge of YBL036C did not include the corresponding structure without PLP. However, the changes associated with the presence or absence of PLP may be highly relevant for a role of COG0325 proteins in PLP delivery to other targets. Although crystal structures of three bacterial COG0325 proteins have been deposited in the Protein Data Bank (PDB) ( Table S1 ), none of these structures has been analyzed, justifying the need for thorough structural analysis of a bacterial COG0325 protein in the absence and the presence of PLP. We carry out here such structural analysis on S. elongatus PipY. The detailed structural information gained in the present studies by X-ray crystallography of PLP-containing and PLP-free PipY makes of PipY a true structural paradigm for COG0325 proteins. In addition, we have characterized some PipY traits in solution, including its mass, its spectroscopic properties, and both its ability to bind PLP and its sensitivity to the PLP-targeting antibiotic DCS. The toxicity of this antibiotic for S. elongatus was previously shown to be increased by pipY inactivation [11] .
We also get insight here on the effects of two PROSC mutations, Pro87Leu and Arg241Gln, reported in patients with vitamin B 6 -dependent epilepsy [17, 18] . Puzzlingly, the clinical severity inferred for these mutations did not parallel the ability of the corresponding mutant PROSC gene forms to complement an E. coli yggS -mutant for its phenotype of increased sensitivity to pyridoxine toxicity [17] . To try to explain these puzzling observations, we have introduced into PipY the mutations corresponding to Pro87Leu and Arg241Gln of PROSC, studying relevant characteristics of the mutant PipY forms. This approach has exploited the apparent universality of COG0325 functions (for which the recent studies on S. elongatus provided strong confirmation [11] ) and the sequence conservation between S. elongatus PipY and human PROSC (Fig. S1 ). In this way, we provide valuable hints on the respective ability and lack of ability of the Pro87Leu and Arg241Gln PROSC mutants to override the mutant phenotype of the yggS -E. coli mutant strain [17] , as well as on the possible mechanism of disease causation by the Arg241Gln PROSC mutation.
Materials and methods
Production of wild-type and mutant PipY To produce PipY with a C-terminal GluHis 6 tag, the pET-22b(+)-2060 plasmid was transformed into E. coli BL21(DE3) (from Novagen), growing the transformed cells in 1-L liquid LB-ampicillin (0.1 mgÁmL
À1
) at 37°C, to~0.8 OD 600 , followed by 3-h induction with 1 mM isopropyl b-D-1-thiogalactopyranoside. All subsequent steps were at 4°C. After centrifugation, the cell pellet, suspended in 30 mL of 25 mM HEPES pH 7.5/0.4 M NaCl/1 mM dithiothreitol (DTT)/1 mM phenyl methyl sulphonyl fluoride/ 20 mM imidazole, was sonicated to disrupt the cells, the suspension was centrifuged, and PipY was purified from the supernatant by Ni-affinity chromatography and imidazole gradient elution (His-Trap HP 1-mL column in an Akta-FPLC, both from GE Healthcare, Madrid, Spain [21] , scaled with AIMLESS [22] , (Table 1) and phased by molecular replacement with Phaser [23] , using for the PipY-Apo dataset a poly-alanine model of YggS from E. coli (PDB entry PDB 1W8G) lacking residues 1-20; and utilizing for PipY-PLP the A subunit of PipY-Apo once it was traced and refined. Refmac5 [24] was used for optimizing the positioning of the two PipY chains present in the asymmetric units of both crystals (Table 1) , using rigid body refinement. It was also used for model refinement, alternating iteratively cycles of restrained refinement and of manual model building with Coot [25] . This last program was used for incorporating PLP (taken from the PDB) to the PipY-PLP model. Isotropic B factors and Translation/Libration/Screw (TLS) were used in the last refinement steps [26] , choosing the TLS groups with the TLSMD server (http://skuld.bmsc.washington.edu/~tlsmd) [27] . All diffraction data were used throughout the refinement processes, except for the randomly selected 5% of the data used for R free calculation. The stereochemistry of the model was checked and improved with PDB_REDO [28] . Analysis with Rampage [29] of the geometry of the main chain torsion angles revealed excellent values for both models. Graphical representations of the structures were generated with PYMOL (Pymol Molecular Graphics System, Version 1.6, Schr€ odinger, LLC, www.pymol.org).
Other techniques
Size exclusion chromatography was performed on a Superdex 200 10/300 column fitted on an € AKTA FPLC (both from GE Healthcare), at 0.5 mLÁmin À1 flow rate, using a solution of 10 mM Na phosphate pH 7.0/0.4 M NaCl/5 mM MgCl 2 /5 mM EDTA/0.2 mM DTT, and monitoring the absorbance of the effluent at 280 nm. The mass of PipY was estimated from a semi-logarithmic plot prepared with protein standards of known masses. Spectrophotometric determinations were carried out with a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA) on 2-lL samples. All reagents and PipY were in storage buffer. Optical absorption values are given for 1-cm light path. Incubations of PipY with PLP or DCS were performed for 15 min in 50 lL solutions at 25°C, with controls lacking PipY carried in parallel and subtracted. For incubation with DCS, PipY had been incubated previously with 0.34 mM PLP and then freed from unbound PLP by centrifugal gel filtration [30] . Plots of the absorbance at 425 nm of PipY Values in parentheses are the data for the highest resolution shell. versus PLP or DCS concentrations were fitted to hyperbolae using GRAPHPADPRISM (GraphPad Software, San Diego, CA, USA). Circular dichroism spectra in the far-UV region (195-250 nm) were obtained at 21°C with a Jasco J-810 spectropolarimeter (Jasco, Easton, MD, USA) in 0.2 mL of 50 mM Na phosphate pH 7.5 and 0.25 mgÁmL À1 protein in a 0.1 cm-path cell. Each spectrum was the average of five scans.
The thermal stabilities of wild-type and mutant PipY proteins were investigated by the thermofluor approach [31] as previously reported [32] , using 0.25 mgÁmL À1 PipY in a solution of 22 mM Hepes pH 7.5 with the indicated additions.
Results
The pipY protein product
PipY was produced in E. coli from an expression plasmid and was obtained in pure form (Fig. 1A, inset) . Similarly to the E. coli and yeast COG0325 gene products, YggS, and YBL036C [12,13,19], PipY was monomeric, judged from its behavior in size exclusion chromatography assays (Fig. 1A) . As expected for a protein forming a protonated Schiff base with PLP [33] , pure PipY was yellow due to a broad optical absorption peak having its maximum absorption at 425 nm (Fig. 1B , black continuous line), a longer wavelength than the maximum for free PLP (Fig. 1B , dotted line). PipY incubation with excess PLP, followed by removal of the PLP excess by centrifugal gel filtration [30] , increased the size of the 425-nm peak (Fig. 1B, dashed line) , as if the pure protein was incompletely saturated with PLP, perhaps because of partial dissociation of PLP during protein isolation and storage. In fact, prolonged PipY storage (several months) decreased the height of the 425-nm peak (Fig. 1B, gray line) , as expected for PLP dissociation with time. Titration with PLP of this aged protein restored maximal absorbance with a K D value for PLP of~30 lM (Fig. 1C) . As is typical for protein-bound PLP [34] , the 425-nm peak disappeared with the addition of DCS (Fig. 1D) , while absorbance at shorter wavelength (around 335 nm) increased. Titration of the decrease in absorbance at 425 nm versus DCS concentrations (Figs. 1D and 1E) yielded a K D for DCS in the mM range, two to three orders of magnitude higher than K D values for PLP-containing proteins that bind DCS as an analog of an amino acid substrate (the case for alanine racemase [15] ). This low affinity for DCS excludes specific binding of this antibiotic to PipY, in agreement with the reported lack of alanine racemase activity of PipY [11] and of the COG0325 gene products of other species [13] .
Overall characteristics of crystalline PipY
PipY crystal structures were determined at~1.9
A resolution with and without PLP (PipY-PLP and PipYApo, respectively; Table 1 ). No electron density that could correspond to D-Ala or DCS was observed in the crystals, despite that these compounds were present at 10 mM concentrations in the respective crystallization solutions (see Materials and Methods). Each crystal had two protein chains in the asymmetric unit. These chains were related by twofold noncrystallographic symmetry. The small contact surfaces (~5% of the exposed surface) and the predictions of the PISA server (www.ebi.ac.uk/pdbe/pisa/) did not support a homodimeric nature of PipY in solution, agreeing with the size exclusion chromatography results that showed that PipY is a monomer (Fig. 1A) .
Except for the initial and final 2-3 residues and the C-terminal His 6 -tag, the entire polypeptide chains were visible in the crystal structures. In addition, one PLP molecule was found binding per chain in the PipY-PLP crystal. Both monomers in each asymmetric unit were essentially identical (r.m.s.d. <0.6
A, Table S1 ), with somewhat lower identity when PLP-containing and PLP-lacking PipY molecules were compared (r.m.s.d. 0.62-0.98 A, Table S1 ). There was high similarity with the reported structure [19] of the yeast COG0325-encoded protein YBL036C or with the structures of another three COG0325 products from other bacteria that are deposited in the PDB (Table S1; 
The structure of PipY
PipY has ( Fig. 2A ) the characteristic type-III fold of PLP-dependent enzymes [19, 35] , a modified TIM barrel [36] having an extra N-terminal a-helix preceding the first of the eight b/a repeating units and lacking the helix of the last repeat. Unlike the paradigms of this fold, alanine racemase, ornithine decarboxylase, and broad specificity amino acid racemase [37] [38] [39] , all of them composed of two-domain subunits forming homodimers, PipY is a single-domain monomer consisting exclusively of the barrel domain (Fig. S2A) . This is also the case for the highly similar structures previously reported for YBL036C [19] or deposited in the PDB for another three bacterial COG0325 proteins (Table S1 ). All these COG0325 protein structures have a one-turn imperfect a helical extension of the C-terminal b-strand (helix 9, Figs 2A and S2A ). This extension binds the phosphate of PLP (see below). However, PipY differs from all the other COG0325-encoded protein products of known structure in the length of the first a-helix (Fig. S2A) , which in PipY spans less than three full turns, while in all these other proteins are much longer on both the N-and C-terminal ends of this helix, which spans up to six turns (Fig. 2B ). Perhaps this helix, which is lacking in canonical TIM barrels, could be involved in interactions with other proteins, with specific requirements for COG0325 proteins of different species.
PLP binding
PLP sits toward the center of the barrel on the C-edge side of the parallel b-sheet ( Fig. 2A) . It is found in the same site and orientation as in yeast YBL036C and in the deposited structures of COG0325 proteins. This location is the same that is found in the PLP enzymes presenting the PLP type-III fold (Fig. S2A-C) . However, in PipY and the other COG0325 proteins of known structure the PLP is much more accessible than in the type-III fold PLP enzymes [37] [38] [39] . In these dimeric enzymes, the cofactor is shielded by the twodomain architecture and by the other subunit, being accessible only through a tunnel (not shown). The exposed PLP of PipY and of other COG0325 proteins should facilitate PLP exchange with other molecular partners. The PLP forms a Schiff base with Lys26 ( Figs 2C and S2C ). Its phosphate is anchored via six hydrogen bonds on helix 9 (residues Gly212 and Thr213) and on the b7-a8 turn (Ser195 and, indirectly through water, Ser196). The cofactor makes other noncovalent interactions with six of the eight b/a repeats of the modified TIM barrel. Only b/a repeats 4 and 5 do not contact the PLP. The pyridoxal ring is partially sandwiched between Leu70 from b3 and Met194 from the b7-a8 turn, lying through its border on Arg210 from b8, with which an NHÁÁÁN hydrogen bond is made. The exposed part of the pyridoxal ring makes contacts through its C2-methyl group with Met152 from b6, hydrogen bonding its C3-OH with Asn47 from b2, and contacting Val24 of b1 via its C4 carbaldehyde and C5 hydroxymethyl groups. Except for the indirect interaction with Ser196 (Fig. 2C) , all PLP interactions found in PipY are present in the other COG0325 structures, either with identical or conservatively replaced residues (Fig.S2A ).
Changes associated with PLP binding in the context of a role of PipY in PLP homeostasis
Our determination of the structures of PLP-bound and PLP-free forms of PipY allowed characterization of the changes associated with PLP binding (Fig. 2D) . These changes are not large, as shown by the modest r.m.s.d. increase when comparing PipY-PLP and PipY-Apo (Table S1 ). The largest changes are experienced by helix 9 (Fig. 2D) , which is displaced toward the PLP phosphate that anchors on it. This helix drags in its movement the residues following it, which are displaced by up to 4.5 A. Helices 1 and 2 are also dragged toward the phosphate, while Ser195 and the b7-a8 loop are displaced by the phosphate, with concomitant small displacement of helix 8, which drags with it helix 7 and the b6-a7 loop, and even helix 6 and the b5-a6 loop.
The movement of helix 9 might be the best candidate for triggering the PLP exchange required for the proposed role of PipY in PLP homeostasis [11] [12] [13] [14] 17, 18] . Due to its exposed nature, helix 9 could interact with other macromolecular players, acting as a trigger for PLP exchange, since a change in the position of helix 9 could importantly weaken PLP binding to PipY, given the PLP-anchoring role of this helix.
Exploiting PipY for investigating the diseasecausing mechanisms of PROSC mutations
Recently, vitamin B 6 -dependent epilepsy was reported in association with null mutations in the human COG0325 gene PROSC [17,18]. However, some patients carried the missense PROSC mutations Pro87-Leu and/or Arg241Gln, two mutations for which a loss-of-function effect was at best hypothetical [18] . In addition, there was no correspondence between the degree of clinical severity attributed to each of these mutations on the basis of the observations on the patients [18] and the ability of each mutant form to complement the increased pyridoxine toxicity phenotype of the yggS -E. coli mutant [17] . Since the PROSC Pro87 and Arg241 residues are conserved in S. elongatus PipY (respective PipY counterparts, Pro63 and Arg210, Fig. S1 ), we investigated the effects of the corresponding PipY mutations on recombinantly produced PipY as an approximation to the effects of PROSC mutations. Both mutant proteins could be purified (Fig. 3A, bottom panel) and were monomeric (determined by size exclusion chromatography, data not shown). The Pro63Leu mutation did not negatively affect any of the parameters assessed: yield (Fig. 3A , top panel), thermal stability (Fig. 3B) , proper fold of the pure protein (estimated by CD, Fig. 3C ), and PLP content (assessed by the absorption spectrum, Fig. 3D ). The latter was to be expected, since Pro63 sits on the opposite face of the TIM barrel than PLP ( Fig. 2A) , and, therefore, the mutations of this residue should not directly hamper PLP binding. In contrast, the Arg210Gln mutant, also obtained in pure (Fig. 3A , bottom panel) and well-folded form (Fig. 3C) , was produced in quite low yield (Fig. 3A, top panel) , exhibited decreased thermal stability (nearly 5°C decrease, Fig. 3B ), and had little if any PLP, judged from its low optical absorption in the 425-nm region (Fig. 3D) . This last observation fits the fact that the mutation affects the invariant arginine shown by the structure to run parallel to the buried border of the pyridoxal ring, with which it makes an NHÁÁÁN hydrogen bond ( Fig. 2A,C) . Our findings explain the results of complementation assays for the Pro87Leu and Arg241Gln PROSC mutants [17] and the disease causality of the Arg241Gln mutation (see Discussion).
Discussion
The complementation of yggS À E. coli by COG0325
genes of other species [12,13,17] and the phenotypic similarities of this E. coli mutant and of the S. elongatus pipY À mutant [11] are strong indications that the function of COG0325 genes is conserved across phyla. The alleviation by PLP or by vitamin B 6 supplementation of the alterations observed in these mutants [11] [12] [13] [14] , best illustrated by the vitamin B 6 dependence of the epilepsy due to PROSC deficiency [17, 18] , indicates that this conserved function is related to PLP, in line with the fact that COG0325 products are PLPcontaining proteins. Yet, previous work [11-13] has not favored an enzymatic role of COG0325 proteins.
In our own work, we have failed to generate crystals of PipY bound to D-Ala or to DCS despite extensive crystallization attempts with these compounds. These two ligands have been found binding in crystals of the structurally similar alanine racemase [40] . Furthermore, as exemplified in the PipY structure, COG0325 proteins lack key constant and obligatory features of type-III fold PLP enzymes [35] . These missing traits include the dimeric character, the presence of a second domain, and the existence of an invariant substratebinding arginine (Arg129 of Ala racemase, Fig. S2A , C) and of a negative charge that stabilizes this arginine [37] [38] [39] [40] [41] . Thus, COG0325 proteins are believed to be involved in PLP homeostasis rather than being catalysts [11] [12] [13] [14] 17, 18] . Table S1 ). PLP is exposed as if it was poised for transfer. Furthermore, the relatively large changes in the orientation of the outwards-protruding helix 9 depending on the presence or absence of PLP, taken together with the key role of this helix in PLP anchoring, render this helix an obvious candidate for being a trigger that could be operated by partners to weaken the interactions of COG0325 proteins with PLP, promoting PLP transfer.
The alternative possibility that COG0325 proteins, although not catalytic by themselves, could be subunits of hypothetical heterodimeric PLP enzymes in which the COG0325 subunit would act as a common PLPcontaining module appears unlikely. The pleiotropic metabolic effects of the null COG0325 gene mutations demand multiple alternative partners for the COG0325 protein. It would be unlikely not to detect any of these partners in yeast two-hybrid assays using PipY as the bait, but, in fact, no partner was detected [11] . Furthermore, the increased amino acid levels in the cerebrospinal fluid of a PROSC-deficient patient [18] fitted multiple transaminase deficiency. However, transaminases do not utilize for binding PLP the modified TIM barrel fold used by COG0325 proteins [35] . Similarly, a role of COG0325 in the regulation of a specific PLP enzyme, as exemplified for ornithine decarboxylase with its enzyme/antizyme/antizyme inhibitor system [43] , cannot be excluded, but, again, appears unlikely, largely because it would not fit the multi-target pleiotropy reflected in the metabolic phenotypes of COG0325 mutants.
Strong support for a PLP-homeostatic role of COG0325 proteins was provided by observations made in vitamin B 6 -dependent epilepsy associated to PROSC mutations [17, 18] . In contrast to the Arg210Gln PipY mutant, the PipY Pro63Leu mutant that mirrors the PROSC Pro87Leu mutant appeared normal. Thus, studies using the PROSC Pro87Leu mutant itself expressed in human cells might be necessary to test experimentally the disease causation and clinical severity attributed to this mutation [18] . In any case, it is interesting that three of the six missense PROSC mutations observed thus far in patients with vitamin B 6 -dependent epilepsy replace proline by leucine or the reverse (Fig. S2A ) [17, 18] . Given the structural uniqueness of proline as a protein amino acid, it is conceivable that these changes could lead to increased PROSC misfolding, raising the possibility of using pharmacological chaperones to try to alleviate the deleterious effects of these missense mutations.
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